7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Non-prescribed antibiotic dispensing practices for symptoms of urinary tract infection in community pharmacies and accredited drug dispensing outlets in Tanzania: a simulated clients approach

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Antibiotic dispensing without prescription is a major determinant of the emergence of Antimicrobial Resistance (AMR) which has impact on population health and cost of healthcare delivery. This study used simulated clients describing UTI like symptoms to explore compliance with regulation, variations in dispensing practices and drug recommendation, and quality of seller-client interaction on the basis of the gender of the client and the type of drug outlets in three regions in Tanzania.

          Method

          A total of 672 Accredited Drug Dispensing Outlets (ADDOs) and community pharmacies were visited by mystery clients (MCs). The study was conducted in three regions of Tanzania namely Kilimanjaro (180, 26.79%), Mbeya (169, 25.15%) and Mwanza (323, 48.07%) in March–May 2020. During data collection, information was captured using epicollect5 software before being analyzed using Stata version 13.

          Results

          Overall, 89.43% (CI: 86.87–91.55%) of drug sellers recommended antibiotics to clients who described UTI like symptoms but held no prescription and 58.93% were willing to sell less than the minimum recommended course. Female clients were more likely than male to be asked if they were taking other medications (27.2% vs 9.8%), or had seen a doctor (27.8% vs 14.7%), and more likely to be advised to consult a doctor (21.6% vs 9.0%); pharmacies addressed these issues more often than ADDOs (17.7% vs 13.2, 23.9% vs 16.6%, 17.7 vs 10.9% respectively). Sellers recommended 32 different drugs to treat the same set of symptoms, only 7 appear in the Tanzanian Standard Treatment Guidelines as recommended for UTI and 30% were 2nd and 3rd line drugs. ADDO sellers recommended 31 drug types (including 2nd and 3rd line) but had permission to stock only 3 (1st line) drugs. The most commonly suggested antibiotics were Azithromycin (35.4%) and ciprofloxacin (20.5%). Azithromycin was suggested more often in pharmacies (40.8%) than in ADDOs (34.4%) and more often to male clients (36.0%) than female (33.1%).

          Conclusion

          These findings support the need for urgent action to ensure existing regulations are adhered to and to promote the continuing professional development of drug sellers at all outlet levels to ensure compliance with regulation, high quality service and better antibiotic stewardship.

          Supplementary Information

          The online version contains supplementary material available at 10.1186/s12875-022-01905-6.

          Related collections

          Most cited references23

          • Record: found
          • Abstract: found
          • Article: not found

          Antibiotic resistance-the need for global solutions.

          The causes of antibiotic resistance are complex and include human behaviour at many levels of society; the consequences affect everybody in the world. Similarities with climate change are evident. Many efforts have been made to describe the many different facets of antibiotic resistance and the interventions needed to meet the challenge. However, coordinated action is largely absent, especially at the political level, both nationally and internationally. Antibiotics paved the way for unprecedented medical and societal developments, and are today indispensible in all health systems. Achievements in modern medicine, such as major surgery, organ transplantation, treatment of preterm babies, and cancer chemotherapy, which we today take for granted, would not be possible without access to effective treatment for bacterial infections. Within just a few years, we might be faced with dire setbacks, medically, socially, and economically, unless real and unprecedented global coordinated actions are immediately taken. Here, we describe the global situation of antibiotic resistance, its major causes and consequences, and identify key areas in which action is urgently needed. Copyright © 2013 Elsevier Ltd. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Global increase and geographic convergence in antibiotic consumption between 2000 and 2015

            Significance Antibiotic resistance, driven by antibiotic consumption, is a growing global health threat. Our report on antibiotic use in 76 countries over 16 years provides an up-to-date comprehensive assessment of global trends in antibiotic consumption. We find that the antibiotic consumption rate in low- and middle-income countries (LMICs) has been converging to (and in some countries surpassing) levels typically observed in high-income countries. However, inequities in drug access persist, as many LMICs continue to be burdened with high rates of infectious disease-related mortality and low rates of antibiotic consumption. Our findings emphasize the need for global surveillance of antibiotic consumption to support policies to reduce antibiotic consumption and resistance while providing access to these lifesaving drugs.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Antimicrobial resistance: a global multifaceted phenomenon.

              Antimicrobial resistance (AMR) is one of the most serious global public health threats in this century. The first World Health Organization (WHO) Global report on surveillance of AMR, published in April 2014, collected for the first time data from national and international surveillance networks, showing the extent of this phenomenon in many parts of the world and also the presence of large gaps in the existing surveillance. In this review, we focus on antibacterial resistance (ABR), which represents at the moment the major problem, both for the high rates of resistance observed in bacteria that cause common infections and for the complexity of the consequences of ABR. We describe the health and economic impact of ABR, the principal risk factors for its emergence and, in particular, we illustrate the highlights of four antibiotic-resistant pathogens of global concern - Staphylococcus aureus, Klebsiella pneumoniae, non-typhoidal Salmonella and Mycobacterium tuberculosis - for whom we report resistance data worldwide. Measures to control the emergence and the spread of ABR are presented.
                Bookmark

                Author and article information

                Contributors
                joseph.mwanga@bugando.ac.tz
                Journal
                BMC Prim Care
                BMC Prim Care
                BMC Primary Care
                BioMed Central (London )
                2731-4553
                19 November 2022
                19 November 2022
                2022
                : 23
                : 287
                Affiliations
                [1 ]GRID grid.411961.a, ISNI 0000 0004 0451 3858, Department of Biostatistics, Epidemiology and Behavioral Sciences, School of Public Health, , Catholic University of Health and Allied Sciences, ; P.O. Box 1464, Mwanza, Tanzania
                [2 ]GRID grid.411961.a, ISNI 0000 0004 0451 3858, Department of Microbiology and Immunology, Weill Bugando School of Medicine, , Catholic University of Health and Allied Sciences, ; P.O. Box 1464, Mwanza, Tanzania
                [3 ]GRID grid.411961.a, ISNI 0000 0004 0451 3858, School of Pharmacy, , Catholic University of Health and Allied Sciences, ; P.O. Box 1464, Mwanza, Tanzania
                [4 ]GRID grid.416716.3, ISNI 0000 0004 0367 5636, National Institute for Medical Research, Mbeya Medical Research Centre, ; P.O. Box 2410, Mbeya, Tanzania
                [5 ]GRID grid.412898.e, ISNI 0000 0004 0648 0439, Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre and Kilimanjaro Christian Medical University College, ; P.O. Box 2236, Moshi, Tanzania
                [6 ]GRID grid.11914.3c, ISNI 0000 0001 0721 1626, Geography and Sustainable Development, , University of St Andrews, ; North Street, St Andrews, KY16 9AL UK
                [7 ]GRID grid.11914.3c, ISNI 0000 0001 0721 1626, Division of Infection and Global Health, School of Medicine, , University of St Andrews, ; North Street, St Andrews, KY16 9AL UK
                Article
                1905
                10.1186/s12875-022-01905-6
                9675131
                36402956
                a05d2ec3-9b8d-4f20-8d21-c24b63a2705b
                © The Author(s) 2022

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 10 December 2021
                : 8 November 2022
                Categories
                Research
                Custom metadata
                © The Author(s) 2022

                antibiotic,antibiotic resistance,dispensing practice,prescription

                Comments

                Comment on this article